Nitric Oxide-Independent Vasodilator Rescues Heme-Oxidized Soluble Guanylate Cyclase From Proteasomal Degradation.

Sabine Meurer, Sylke Pioch, Tatjana Pabst, Nils Opitz, Peter M Schmidt, Tobias Beckhaus, Kristina Wagner, Simone Matt, Kristina Gegenbauer, Sandra Geschka, Michael Karas, Johannes-Peter Stasch, Harald H H W Schmidt, Werner Müller-Esterl

Department of Pharmacology & Centre for Vascular Health, Monash University, Melbourne, Clayton, Australia; Institute of Biochemistry II, University of Frankfurt Medical School, Germany; Institute of Pharmaceutical Chemistry, University of Frankfurt, Germany; Institute of Cardiovascular Research, Bayer HealthCare AG, Wuppertal, Germany; School of Pharmacy, Martin-Luther-University, Halle, Germany; and Department of Pharmacology, University of Cologne, Germany.

Journal Article: Circulation Research (impact factor: 9.21). 06/2009; DOI: 10.1161/CIRCRESAHA.109.198234

Abstract

Nitric oxide (NO) is an essential vasodilator. In vascular diseases, oxidative stress attenuates NO signaling by both chemical scavenging of free NO and oxidation and downregulation of its major intracellular receptor, the alphabeta heterodimeric heme-containing soluble guanylate cyclase (sGC). Oxidation can also induce loss of the heme of sGC, as well as the responsiveness of sGC to NO. sGC activators such as BAY 58-2667 bind to oxidized/heme-free sGC and reactivate the enzyme to exert disease-specific vasodilation. Here, we show that oxidation-induced downregulation of sGC protein extends to isolated blood vessels. Mechanistically, degradation was triggered through sGC ubiquitination and proteasomal degradation. The heme-binding site ligand BAY 58-2667 prevented sGC ubiquitination and stabilized both alpha and beta subunits. Collectively, our data establish oxidation-ubiquitination of sGC as a modulator of NO/cGMP signaling and point to a new mechanism of action for sGC activating vasodilators by stabilizing their receptor, oxidized/heme-free sGC.

Source: PubMed

Comments on this publication

ResearchGate members can add comments. Sign up now and post your comment!

Similar publications

Science & Research Jobs

Keywords

alphabeta heterodimeric heme-containing soluble guanylate cyclase
 
degradation
 
disease-specific vasodilation
 
free
 
heme
 
heme-binding site ligand BAY 58-2667
 
major intracellular receptor
 
modulator
 
new mechanism
 
Nitric oxide
 
NO/cGMP signaling
 
oxidized/heme-free sGC
 
proteasomal degradation
 
responsiveness
 
sGC
 
sGC activating vasodilators
 
sGC protein
 
sGC ubiquitination
 
signaling
 
vascular diseases